Literature DB >> 8969839

Strategy for controlling preferential amplification and avoiding false negatives in PCR typing.

T Weissensteiner1, J S Lanchbury.   

Abstract

The use of the PCR method for routine testing has increased dramatically during recent years. Most assays involve co-amplification either of an internal control, of several alleles at a given locus or of a variety of bands produced by low-stringency primer annealing. In such multiplex reactions, certain products will often amplify preferentially. Amplimers that are more sensitive can be outcompeted under suboptimal PCR conditions, leading to assignment of false negatives. Optimization of PCR parameters such as temperature steps, relative concentrations of primers and their annealing temperature do not alone ensure against false negatives when caused by stable double-stranded DNA (dsDNA) regions in the amplified sequence. A two-step strategy to solve this problem is presented in this paper: (i) titration of the PCR with NaCl as a model inhibitor to establish the critical range within which false negatives occur; (ii) titration of the PCR with a dsDNA-destabilizing additive under false-negative-inducing conditions until the relative amplification efficiencies of co-amplified fragments are adjusted. Betaine is introduced as a novel and efficient cosolute. These measures to achieve reliable PCR typing of a difficult target should be useful for many qualitative and quantitative multiplex PCR applications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8969839     DOI: 10.2144/96216rr03

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  30 in total

1.  Rapid discrimination of monkey B virus from human herpes simplex viruses by PCR in the presence of betaine.

Authors:  M Hirano; S Nakamura; M Okada; M Ueda; R Mukai
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  New specificity and yield enhancer of polymerase chain reactions.

Authors:  M Kovárová; P Dráber
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

3.  Spectrum of nonrandom associations between microsatellite loci on human chromosome 11p15.

Authors:  C Zapata; S Rodríguez; G Visedo; F Sacristán
Journal:  Genetics       Date:  2001-07       Impact factor: 4.562

4.  Sequencing in the presence of betaine: Improvement in sequencing of the localized repeat sequence regions.

Authors:  T Haqqi; X Zhao; A Panciu; S P Yadav
Journal:  J Biomol Tech       Date:  2002-12

5.  Angiotensin-converting enzyme insertion/deletion polymorphism genotyping error: the cause and a possible solution to the problem.

Authors:  Andrea Saracevic; Ana-Maria Simundic; Ivana Celap; Valentina Luzanic
Journal:  Mol Biol Rep       Date:  2013-05-09       Impact factor: 2.316

6.  Localised sequence regions possessing high melting temperatures prevent the amplification of a DNA mimic in competitive PCR.

Authors:  D G McDowell; N A Burns; H C Parkes
Journal:  Nucleic Acids Res       Date:  1998-07-15       Impact factor: 16.971

7.  Effect of transition metal ions on the fluorescence and Taq-catalyzed polymerase chain reaction of tricyclic cytidine analogs.

Authors:  Gudrun Stengel; Byron W Purse; Robert D Kuchta
Journal:  Anal Biochem       Date:  2011-04-27       Impact factor: 3.365

8.  Utility of amplification enhancers in low copy number DNA analysis.

Authors:  Pamela L Marshall; Jonathan L King; Bruce Budowle
Journal:  Int J Legal Med       Date:  2014-05-22       Impact factor: 2.686

9.  A critical analysis of Atoh7 (Math5) mRNA splicing in the developing mouse retina.

Authors:  Lev Prasov; Nadean L Brown; Tom Glaser
Journal:  PLoS One       Date:  2010-08-24       Impact factor: 3.240

10.  Tuberculosis in Dr Granville's mummy: a molecular re-examination of the earliest known Egyptian mummy to be scientifically examined and given a medical diagnosis.

Authors:  Helen D Donoghue; Oona Y-C Lee; David E Minnikin; Gurdyal S Besra; John H Taylor; Mark Spigelman
Journal:  Proc Biol Sci       Date:  2009-09-30       Impact factor: 5.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.